GlassScriptPhysician profile
Amelia Nocon
NPI 1437805595
$1,555.05
in general payments reported to CMS, 2019-2025
26 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $462 · 2023: $467 · 2024: $131 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.20 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $331.58 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $229.62 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $210.95 | 2022-2023 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $128.43 | 2022-2025 | Tezspire, Farxiga, Breztri |
| Biohaven Pharmaceutical Holding Company LTD. | $64.74 | 2022 | |
| Esperion Therapeutics, INC. | $62.54 | 2022-2023 | Nexletol |
| Novo Nordisk INC | $50.38 | 2022 | |
| Abbvie INC. | $48.99 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $41.39 | 2022 | |
| Tolmar, INC. | $38.21 | 2023 | |
| Tris Pharma INC | $38.17 | 2023 | Dyanavel Xr |
| Dexcom, INC. | $35.51 | 2023 | Dexcom G6 Transmitter |
| Corium, LLC | $33.21 | 2023 | Azstarys |
| Glaxosmithkline, LLC. | $31.51 | 2023-2024 | Shingrix, Nucala |
| Noven Therapeutics, LLC | $23.47 | 2023 | Xelstrym |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.12 | 2022 | |
| Exact Sciences Corporation | $21.39 | 2023 | Cologuard Collection Kit |
| Neos Therapeutics, LP | $19.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.20 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.01 | 2022 | |
| Integra Lifesciences Corporation | $16.86 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Nevro Corp. | $16.44 | 2023 | Senza |
| Resmed Corp | $14.48 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $14.07 | 2022 | |
| Inspire Medical Systems, INC. | $13.71 | 2025 | Inspire |
| Supernus Pharmaceuticals, INC. | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amelia Nocon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.